AlphaRx to Conduct R&D inside Venturepharm’s Taizhou Facility

AlphaRx Inc. released details of its recently announced China collaboration with Venturepharm. AlphaRx, a company that adds its proprietary drug delivery technology to established pharmaceuticals, will establish an R&D facility inside of Venturepharm’s preclinical development facility, which is located in Taizhou’s China Medical City. For AlphaRx, the goal is to develop products for the China market. More details... Stock Symbol: (OTCBB: ALRX)